Mount Sinai Logo

Lawrence Newman

  • PROFESSOR Neurology
Print ProfilePrint Profile



  • American Board of Psychiatry and Neurology


  • MD, State University of Guadalajara Medical School

  • Residency, Neurology
    Albert Einstein College of Medicine

  • Internship, 5TH Pathway
    * Elmhurst Hospital Center *

  • Residency, Internal Medicine
    * Elmhurst Hospital Center *

  • Fellowship, HEADACHE UNIT
    * Montefiore Medical Center - GME *

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Newman during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • NuPathe Inc. (Teva Pharmaceutical Industries); Zogenix, Inc.

Scientific Advisory Board:

  • Allergan, Inc. / MAP Pharmaceuticals, Inc. collaboration; NuPathe Inc. (Teva Pharmaceutical Industries); Zogenix, Inc.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Allergan, Inc.; Allergan, Inc. / MAP Pharmaceuticals, Inc. collaboration

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central